Avances en enfermedades digestivas
Evidencias en la prevención del cáncer colorrectal

BIBLIOGRAFÍA

1.Grupo de trabajo de la Guía de Práctica clínica de Prevención del Cáncer Colorrectal. Guía de practica clínica. Barcelona: Asociación Española de Gastroenterología, Sociedad Española de Medicina de Familia y Comunitaria y Centro Cochrane Iberoamericano;2004, Programa de Elaboración de Guías de Práctica Clínica en Enfermedades Digestivas, desde la Atención Primaria a la Especializada. Disponible en http://www.semfyc.es2. Castells A, Marzo M, Bellas B, Amador FJ,Lanas A, Mascort JJ, et al. Guía de Práctica clínica sobre la prevención del cáncer colorrectal. Gastroenterol Hepatol.2004;27;573-6343. Mortalidad por cáncer y otras causas en España, año 2000. Centro Nacional de Epidemiología, 2000. En: http://193.146.50.130/cancer/cancer1.htm. 4. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642. [Medline] 5. Piñol V, Andreu M, Castells A, Payá A, Bessa X, Jover R. Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain. A multicenter, prospective, nation-wide study. Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Eur J Gastroenterol Hepatol [en prensa]. 6. Gatta G, Capocaccia R, Coleman MP, Gloeckler Ries LA, Hakulinen T, Micheli A et al. Toward a comparison of survival in American and European cancer patients. Cancer 2000; 89: 893-900. [Medline] 7.Propuesta de Recomendación del Consejo sobre Cribado del Cáncer. Comisión de las Comunidades Europeas;2003. Disponible en ; http//www.who.int/cancer/ncp/en/ecproposalforcouncilrecommendationes.pdf 8. Plan Integral del Cáncer. Detección precoz. Dirección General Agencia de Calidad; 200. Disponible en http://www.msc.es/Diseno/planesIntegrales/planes-integrales.htm9. Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr 1997; 66: 1.564S-1.571S. [Medline] 10. Norat T, Riboli E. Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence. Eur J Clin Nutr 2003; 57: 1-17. [Medline] 11. Sandhu MS, White IR, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev 2001; 10: 439-446. [Medline] 12. Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-anáalysis of epidemiological studies. Int J Cancer 2002; 98: 241-256. [Medline] 13.Colorectal cancer screening. Recommendation statement from the Canadian Task force on Preventive Health Care. CMAJ.2001;165;206-8 14.US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Interen Med.2002; 137;129-31 15. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78: 559S-569S. [Medline] 16. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 2003; 361: 1.496-1.501. [Medline] 17. Asano T, McLeod R. Dietary fibre for the prevention of colorectal adenomas and carcinomas (Cochrane Review). En: The Cochrane Library. Chichester, UK: John Wiley & Sons Ltd, 2003. 18. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 2003; 361: 1.491-1.495. [Medline] 19. Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 1998; 7: 163-168. [Medline] 20. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr., , Slate EH, Fischbach LA et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002; 11: 630-639. [Medline] 21. IARC Working Group on the Evaluation of Cancer-Preventive Agents. Weight control and physical activity. Handbooks of cancer prevention, vol. 6. Lyon: IARC Press, 2002. 22. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001; 85: 1.700-1.705. [Medline] 23. Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 2001; 12: 88-93. [Medline] 24. Gatof D, Ahnen D. Primary prevention of colorectal cancer: diet and drugs. Gastroenterol Clin North Am 2002; 31: 587-623. [Medline] 25. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348: 891-899. [Medline] 26. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106: 574-582. [Medline] 27. Scottish Intercollegiate Guidelines Network (SIGN). Management of colorectal cancer, 2003. En: http://www.sign.ac.uk/pdf/sign67.pdf 28. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003; 124: 544-560. [Medline] 29. Marzo M. Diagnóstico rápido de cáncer. Cuadernos de gestión 2002; 25-36. 30. Potter MA, Wilson RG. Diagnostic delay in colorectal cancer. J R Coll Surg Edinb 1999; 44: 313-316. [Medline] 31. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000; 95: 868-877. [Medline] 32. Rhodes JM. Colorectal cancer screening in the UK: Joint Position Statement by the British Society of Gastroenterology, The Royal College of Physicians, and The Association of Coloproctology of Great Britain and Ireland. Gut 2000; 46: 746-748. [Medline] 33. Burt RW. Colon cancer screening. Gastroenterology 2000; 119: 837-853. [Medline] 34. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002; 137: 129-131. [Medline] 35. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 132-141. [Medline] 36. Screening for colorectal cancer in adults systematic evidence review. Agency for Healthcare Research and Quality; 2002. En: http://www.ahcpr.gov/clinic/uspstf/uspscolo.htm 37. Walsh JM, Terdiman JP. Colorectal cancer screening: scientific review. JAMA 2003; 289: 1.288-1.296. [Medline] 38. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003; 53: 27-43. [Medline] 39. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1.365-1.371. [Medline] 40. Towler B, Irwig L, Glasziou P, Weller D, Kewenter J. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Cochrane Database Systematic Review 2000; 2: CD001216. 41. Scholefield JH, Moss SM. Faecal occult blood screening for colorectal cancer. J Med Screen 2002; 9: 54-55. [Medline] 42. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1.603-1.607. [Medline] 43. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343: 162-168. [Medline] 44. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169-174. [Medline] 45. Lewis JD, Ng K, Hung KE, Bilker WB, Berlin JA, Brensinger C et al. Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med 2003; 163: 413-420. [Medline] 46.- Macafee DA, Scholefield JH. Antagonist: population based endoscopic screening for colorectal cancer. Gut 2003; 52: 323-326. [Medline] 47. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85: 1.311-1.318. [Medline] 48.- Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 96-104. [Medline] 49.-Frazier AL, Colditz GA, Fuchs CS, Kuntz KM109. Cost-effectiveness of screening for colorectal cancer in the general population.JAMA.2000; 2841954-61 50.- Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-932. [Medline]

 

volver